Efamed/Efamed Plus Use In Pregnancy & Lactation

Efamed tablet/syrup: Administration of drugs during pregnancy should only be considered if the expected benefit to the mother is greater than any possible risk to the fetus. As salbutamol is probably secreted in breast milk its use in nursing mothers is not recommended unless the expected benefit outweighs any potential risk. It is not known whether salbutamol in breast milk has a harmful effect on the neonate.
Efamed Plus tablet/syrup: Guaifenesin has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Guaifenesin is only recommend for use during pregnancy when benefit outweighs risk.
There are no data on the excretion of guaifenesin into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.